Bioscience firm makes progress on another kind of vaccine

Making good long-term decisions, the lifeblood of any thriving business, is a pressure-packed task at Morphogenesis. The impact — good or bad — could take years to materialize.

Courtesy. Tampa-based Morphogenesis, run by CEO Dr. Patricia Lawman, is targeting skin cancers for research.
Courtesy. Tampa-based Morphogenesis, run by CEO Dr. Patricia Lawman, is targeting skin cancers for research.
  • Strategies
  • Share

The word vaccine carries heavy weight these days, with its tantalizing possibilities to curb the destruction brought on by a certain C-word.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • February 24, 2026
Fort Myers senior living facility gets new operator
  • February 24, 2026
Tampa casino names new president
  • February 24, 2026
First Watch CFO, who guided $1.2B company's IPO, to retire
  • February 23, 2026
Tampa apartments sell to Seattle multifamily investor

Sponsored Content